Santa Barbara, CALIFORNIA2 Active Studies

Ovarian Cancer Clinical Trials in Santa Barbara, CALIFORNIA

Find 2 actively recruiting ovarian cancer clinical trials in Santa Barbara, CALIFORNIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
400
Enrolling

Recruiting Ovarian Cancer Studies in Santa Barbara

About Ovarian Cancer Clinical Trials in Santa Barbara

Ovarian cancer originates in the ovaries or fallopian tubes and is often called a "silent killer" due to subtle early symptoms. It is the fifth leading cause of cancer death among women. Treatment typically involves surgery and chemotherapy, with newer targeted therapies showing promise.

There are currently 2 ovarian cancer clinical trials recruiting participants in Santa Barbara, CALIFORNIA. These studies are seeking a combined 400 participants. Research is being sponsored by TORL Biotherapeutics, LLC, K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ovarian Cancer Clinical Trials in Santa Barbara — FAQ

Are there ovarian cancer clinical trials in Santa Barbara?

Yes, there are 2 ovarian cancer clinical trials currently recruiting in Santa Barbara, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Santa Barbara?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Barbara research site will contact you about next steps.

Are clinical trials in Santa Barbara free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Santa Barbara studies also compensate for your time and travel.

What ovarian cancer treatments are being tested?

The 2 active trials in Santa Barbara are testing new therapies including novel drugs, biologics, and treatment approaches for ovarian cancer.

Data updated March 2, 2026 from ClinicalTrials.gov